Correlation Between Inovio Pharmaceuticals and Vaxart

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and Vaxart at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and Vaxart into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and Vaxart Inc, you can compare the effects of market volatilities on Inovio Pharmaceuticals and Vaxart and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of Vaxart. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and Vaxart.

Diversification Opportunities for Inovio Pharmaceuticals and Vaxart

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Inovio and Vaxart is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and Vaxart Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxart Inc and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with Vaxart. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxart Inc has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and Vaxart go up and down completely randomly.

Pair Corralation between Inovio Pharmaceuticals and Vaxart

Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to generate 0.69 times more return on investment than Vaxart. However, Inovio Pharmaceuticals is 1.44 times less risky than Vaxart. It trades about 0.01 of its potential returns per unit of risk. Vaxart Inc is currently generating about -0.08 per unit of risk. If you would invest  178.00  in Inovio Pharmaceuticals on December 28, 2024 and sell it today you would lose (5.00) from holding Inovio Pharmaceuticals or give up 2.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Inovio Pharmaceuticals  vs.  Vaxart Inc

 Performance 
       Timeline  
Inovio Pharmaceuticals 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Inovio Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Inovio Pharmaceuticals is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Vaxart Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vaxart Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Inovio Pharmaceuticals and Vaxart Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inovio Pharmaceuticals and Vaxart

The main advantage of trading using opposite Inovio Pharmaceuticals and Vaxart positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, Vaxart can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxart will offset losses from the drop in Vaxart's long position.
The idea behind Inovio Pharmaceuticals and Vaxart Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Volatility Analysis
Get historical volatility and risk analysis based on latest market data